Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Non-cash Items (2019 - 2024)

Historic Non-cash Items for Fortress Biotech (FBIO) over the last 5 years, with Q4 2024 value amounting to $1.0 million.

  • Fortress Biotech's Non-cash Items changed N/A to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Fortress Biotech's Non-cash Items stood at $1.0 million.
  • In the past 5 years, Fortress Biotech's Non-cash Items ranged from a high of $400.0 million in Q1 2024 and a low of $100000.0 during Q4 2022
  • Its 4-year average for Non-cash Items is $38.5 million, with a median of $600000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Non-cash Items was 6656666.67% (2024), while the steepest drop was 0.0% (2024).
  • Over the past 4 years, Fortress Biotech's Non-cash Items (Quarter) stood at $17.5 million in 2020, then crashed by 99.43% to $100000.0 in 2022, then soared by 300.0% to $400000.0 in 2023, then skyrocketed by 150.0% to $1.0 million in 2024.
  • Its Non-cash Items was $1.0 million in Q4 2024, compared to $600000.0 in Q3 2024 and $600000.0 in Q2 2024.